Company news

Cyclopharm Limited news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Cyclopharm 2018 First Half Preliminary Headline Update

August 8, 2018

CYC 2018 AGM Presentation

May 29, 2018

Better Defining Airways Disease with Technegas

May 17, 2018

Cyclopharm Acquires Scandinavian Distribution Business

May 6, 2018

40 Patient Milestone Achieved For Technegas USFDA Trial

March 28, 2018

CYC CEO Presentation 2017 Australian Microcap Conference

October 17, 2017

Technegas USFDA Clinical Trial - Patient Enrolment Underway

September 26, 2017

Technegas USFDA Clinical Trial - Patient Enrolment Underway

September 25, 2017

Cyclopharm acquires European distribution business

September 19, 2017

Advancing Molecular Imaging in NSW

September 18, 2017

Dividend/Distribution - CYC

August 28, 2017

Nuclear imaging trial aiming to clear up airway diagnosis

August 18, 2017

CYC Entitlement Offer Closed

July 6, 2017

CYC Entitlement Offer Booklet

June 13, 2017

Entitlement Offer

June 4, 2017

CYC - Positive Results of China Clinical Trial

May 31, 2017

Cyclopharm Amended 2016 Preliminary Financial Report

February 26, 2017

CYC 2016 preliminary headline update-record results

February 6, 2017

CYC Achieves USFDA Agreement For Technegas Trial Design

November 23, 2016

Cyclopharm Business Update on Significant Milestones

October 12, 2016

Appendix 4D and Half Year Accounts

August 19, 2016

CYC Signs Agreement with the Canadian Association of Nuc Med

June 27, 2016

Trading Update & Record Technegas Order Received from China

June 21, 2016

Cyclopharm to Proceed Independently with FDA Trials

May 10, 2016

Cyclopharm Files Claim Against ANSTO

March 30, 2016

Trading Update

March 30, 2016

Renounceable Rights Issue and Sale of Unmarketable Parcels

March 30, 2016

Renewal of Debt Facility with National Australia Bank

March 30, 2016

Regulatory Approval in China

March 30, 2016

Clinical Protocol Approval from US FDA

March 30, 2016

Offer Booklet for Renounceable Rights Issue

March 30, 2016

Technegas COPD Trial Update

February 11, 2016

Update on Cyclotron Facility

February 10, 2016

Technegas May Facilitate Earlier Diagnosis of COPD

February 10, 2016

Technegas Clinical Trial - First Patient Enrolled

February 10, 2016

Results of Mediation

February 10, 2016

Renounceable Issue

February 10, 2016

Offer Booklet

February 10, 2016

Japanese Regulatory Approval received

February 10, 2016

Cyclotron Facility Suffers Significant Water Damage

February 10, 2016

Cyclopharm to Establish Operations in Queensland

February 10, 2016

Cyclopharm to cease Cyclotron commercial operations

February 10, 2016

Cyclopharm signs Term Sheet with Jubilant Draximage

February 10, 2016

Cyclopharm receives insurance settlement

February 10, 2016

Cyclopharm Receives Approval from United States FDA

February 10, 2016

Cyclopharm Develops New Nuclear Medicine Technology

February 10, 2016

← Newer news releases

Decks

The 5 newest of 54 decks. Every deck is listed under its year.